ScholarLens Back to search
2010•Postgraduate MedicineRequires access

Review of the ESPRIT Study: Aspirin plus Dipyridamole versus Aspirin Alone for Prevention of Vascular Events after a Noncardioembolic, Mild-to-Moderate Ischemic Stroke or Transient Ischemic Attack

Halina White, Dara G. Jamieson

Open publisher page 4 citations

Abstract

Practice PearlThis trial demonstrated the efficacy of combination therapy with dosages of aspirin (30–325 mg/day) plus dipyridamole (200 mg twice daily) in the prevention of vascular events after a noncardioembolic, mild-to-moderate ischemic stroke or transient ischemic attack, and showed a clear benefit of the aspirin/dipyridamole combination regimen over an aspirin-alone (30–325 mg/day) regimen.

About this research paper

What this paper is about

Practice PearlThis trial demonstrated the efficacy of combination therapy with dosages of aspirin (30–325 mg/day) plus dipyridamole (200 mg twice daily) in the prevention of vascular events after a noncardioembolic, mild-to-moderate ischemic stroke or transient ischemic attack, and showed a clear benefit of the aspirin/dipyridamole combination regimen over an aspirin-alone (30–325 mg/day) regimen.

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Practice PearlThis trial demonstrated the efficacy of combination therapy with dosages of aspirin (30–325 mg/day) plus dipyridamole (200 mg twice daily) in the prevention of vascular events after a noncardioembolic, mild-to-moderate ischemic stroke or transient ischemic attack, and showed a clear benefit of the aspirin/dipyridamole combination regimen over an aspirin-alone (30–325 mg/day) regimen.

Key concepts: Dipyridamole, Aspirin, Medicine, Regimen, Dose, Stroke (engine), Cardiology, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Review of the ESPRIT Study: Aspirin plus Dipyridamole versus Aspirin Alone for Prevention of Vascular Events after a Noncardioembolic, Mild-to-Moderate Ischemic Stroke or Transient Ischemic Attack — Research Paper | ScholarLens